Evidence map›Paper›PMID 21858200›Full record

ArticlePloS one2011

Mast cells are critical for protection against peptic ulcers induced by the NSAID piroxicam.

Daniel D Hampton, Laura P Hale

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Daniel D HamptonDivision of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Laura P Hale
Duke Medical Center · US

Funding

Chemoprevention of IBD-Associated Colon CancerR01CA115480 · NCI · DUKE UNIVERSITY · PI HALE, LAURA P. · 2006 to 2010
$1.2M
Mast Cells and IBD PathogenesisR21DK075522 · NIDDK · DUKE UNIVERSITY · PI HALE, LAURA P. · 2006 to 2007
$423k
NCI NIH HHS CA115480NCI NIH HHS R01 CA115480NIDDK NIH HHS R21 DK075522NIDDK NIH HHS R21DK75522
6 · The paper itself

Abstract

Many commonly used non-steroidal anti-inflammatory drugs (NSAIDs) also cause gastrointestinal toxicity, including the development of life-threatening peptic ulcers. We report that mast cell-deficient mice have an extremely high incidence of severe peptic ulceration when exposed to the NSAID piroxicam. This enhanced ulcer susceptibility can be reversed by reconstitution with mast cells. Furthermore, wild type mice treated with diphenhydramine hydrochloride, a commonly used antihistamine that blocks histamine H1 receptors, develop a similarly high incidence of peptic ulcers following piroxicam exposure. The protective effect of mast cells is independent of TNF, blockade of H2 receptors, or acid secretion. These data indicate a critical role for mast cells and the histamine that they produce in prevention and/or repair of piroxicam-induced gastric mucosal injury. Additional studies will be required to determine whether this represents a NSAID class effect that can be exploited to develop novel therapeutic strategies to limit the incidence of NSAID-induced side effects in humans.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalCell ProliferationCell SurvivalCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsDiphenhydramineDose-Response Relationship, DrugDrug SynergismGastric MucosaHistamineHumansMast CellsMiceMice, 129 StrainAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsDiphenhydramineHistaminePiroxicamTumor Necrosis Factor-alpha

Identifiers

PMID21858200
PMCPMC3155563
OpenAlexW2009188723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.